4 D Path
Biotechnology, 11 John St, Newton, Massachusetts, 02459, United States, 1-10 Employees
Phone Number: +16*********
Who is 4D PATH
Just because you cant see something, doesnt mean its not there. 4D Paths patented precision oncology platform is designed to unveil previously hidden data to instantly provide biomarker p...
Read More
- Headquarters: 11 John St, Newton, Massachusetts, 02459, United States
- Date Founded: 2016
- Employees: 1-10
- Revenue: Under $1 Million
- Active Tech Stack: See technologies
Industry: Biotechnology
4D Path Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding 4D Path
Answer: 4D Path's headquarters are located at 11 John St, Newton, Massachusetts, 02459, United States
Answer: 4D Path's phone number is +16*********
Answer: 4D Path's official website is https://4dpath.com
Answer: 4D Path's revenue is Under $1 Million
Answer: 4D Path has 1-10 employees
Answer: 4D Path is in Biotechnology
Answer: 4D Path contact info: Phone number: +16********* Website: https://4dpath.com
Answer: Just because you cant see something, doesnt mean its not there. 4D Paths patented precision oncology platform is designed to unveil previously hidden data to instantly provide biomarker profiling and stratification directly from H&E whole slide biopsy/resection images only. 4D Paths cloud-based, quantitative approach is intended to eliminate the need for additional molecular tests (e.g., immunohistochemistry, FISH, RNA-Seq, NGS), accelerating complete, actionable and objective insight leading to expedited and democratized precision medicine. 4D Paths quantitative approach is designed to provide clinical solutions in both companion diagnostics and translational medicine without compromising the current standard of care to reduce the cost, time and complexity of patient care and management, and clinical trials. Our patented methods and integrated platform combine universal physics, biology and mathematical principles to identify tumor-specific phenotypic and genotypic fingerprints in order to inform treatment selection and stratify patients accordingly. The U.S. Food & Drug Administration (FDA) has granted 4D Path Breakthrough Device Designation for our first software-as-a-medical-device solution, the 4D Q-plasia OncoReader Breast, which demonstrates promise of significant improvements over the existing standard of care by providing histopathologists with an adjunct technology to improve diagnostic accuracy of breast cancer features (e.g., its invasiveness, grades, etc.) solely from digitized histopathology images obtained via biopsies or resections.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month